Ann Kellett

100%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

No current examples available.

Conflicts of Interest

No current examples available.

Contradictions

No current examples available.

Deceptions

No current examples available.

Recent Articles

RSV Monoclonal Antibody Products Show 90% Effectiveness in Preventing Hospitalization for Children and Infants During RSV Season

RSV Monoclonal Antibody Products Show 90% Effectiveness in Preventing Hospitalization for Children and Infants During RSV Season

Broke On: Friday, 08 March 2024 A new study shows that two monoclonal antibody treatments, Beyfortus and nirsevimab, can effectively prevent RSV hospitalization in infants. These treatments are given as a single dose at the first sign of symptoms or before exposure to high-risk settings. Parents should be aware of the signs of RSV and seek medical help if their child has difficulty breathing or bluish skin.